Guardant Health
GH
#981
Rank
C$34.33 B
Marketcap
C$255.88
Share price
2.54%
Change (1 day)
158.13%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2025

Annual Report 2025

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2023

Annual Report 2023

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Guardant Health
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report